International Union of Pharmacology. XII. Classification of opioid receptors.

Facing the rapidly spreading novel coronavirus disease (COVID-19), evidence to inform decision-making at both the clinical and policy-making level is highly needed. Based on the results of a study by Petrilli et al, we have developed a calculator using patient data at admission to predict the risk of critical illness (intensive care unit admission, use of mechanical ventilation, discharge to hospice, or death). We report a retrospective validation of the risk calculator on 145 consecutive patients admitted with COVID-19 to a single hospital in Israel. Of the 18 patients with critical illness, 17 were correctly identified by the model(sensitivity: 94.4%, 95% CI, 72.7% to 99.9%; specificity: 81.9%, 95% CI, 74.1% to 88.2%). Of the 127 patients with non-critical illness, 104 were correctly identified. This, despite considerable differences between the original and validation study populations. Our results show that data from published knowledge can be used to provide reliable, patient level, automated risk assessment, potentially reducing the cognitive burden on physicians and helping policy makers better prepare for future needs.

[1]  Heng Xu,et al.  OHMEFENTANYL——A NEW AGONIST FOR μ-OPIATE RECEPTOR , 1985 .

[2]  D. Grandy,et al.  Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine. , 1995, Molecular pharmacology.

[3]  S. Childers,et al.  Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes. , 1989, Molecular pharmacology.

[4]  Y. Wong,et al.  Activation of Type II Adenylyl Cyclase by the Cloned μ‐Opioid Receptor: Coupling to Multiple G Proteins , 1995, Journal of neurochemistry.

[5]  P. Stewart,et al.  Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. , 1993, The Journal of pharmacology and experimental therapeutics.

[6]  G. Kreil,et al.  cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  V. Hruby,et al.  Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  J. Chen,et al.  Ohmefentanyl--a new agonist for mu-opiate receptor. , 1985, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences.

[9]  J. Meunier,et al.  μ‐Opioid Receptors and Not K‐Opioid Receptors Are Coupled to the Adenylate Cyclase in the Cerebellum , 1990 .

[10]  G. Pasternak,et al.  Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. , 1995, Trends in pharmacological sciences.

[11]  G. Pasternak,et al.  Meptazinol: a novel Mu-1 selective opioid analgesic. , 1984, Journal of Pharmacology and Experimental Therapeutics.

[12]  B. Roques,et al.  δ‐Opioid mediated inhibitions of acute and prolonged noxious‐evoked responses in rat dorsal horn neurones , 1989, British journal of pharmacology.

[13]  P. Schiller,et al.  Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist. , 1995, Life sciences.

[14]  W. Bowen,et al.  Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[15]  P. Portoghese,et al.  Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. , 1995, European Journal of Pharmacology.

[16]  H. Emrich,et al.  Psychotomimesis mediated by kappa opiate receptors , 1986, Science.

[17]  Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. , 1995, Journal of neurochemistry.

[18]  H. Yamamura,et al.  Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. , 1992, The Journal of pharmacology and experimental therapeutics.

[19]  Shigetada Nakanishi,et al.  Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor , 1982, Nature.

[20]  G. Uhl,et al.  -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. , 1994, The Journal of biological chemistry.

[21]  M. Kelly,et al.  Opioids act at μ-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance , 1990, Brain Research.

[22]  L. Buéno,et al.  Central μ-, δ- and κ-opioid influences on intestinal water and electrolyte transport in dogs , 1988, Regulatory Peptides.

[23]  I. Ferrer,et al.  Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice. , 1994, The Journal of pharmacology and experimental therapeutics.

[24]  M. E. Lewis,et al.  Pharmacological and anatomical evidence of selective μ, δ, and χ opioid receptor binding in rat brain , 1986, Brain Research.

[25]  G. Bell,et al.  Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. , 1994, Molecular pharmacology.

[26]  V. Hruby,et al.  SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. , 1995, The Journal of pharmacology and experimental therapeutics.

[27]  A. Goldstein,et al.  Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Pasternak,et al.  Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice. , 1992, The Journal of pharmacology and experimental therapeutics.

[29]  W. Sadee,et al.  A human neuroblastoma cell line expresses mu and delta opioid receptor sites. , 1986, The Journal of biological chemistry.

[30]  G. Pasternak,et al.  Naloxone benzoylhydrazone (NalBzoH) analgesia. , 1990, The Journal of pharmacology and experimental therapeutics.

[31]  E. Barnard,et al.  Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Lahti,et al.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. , 1983, The Journal of pharmacology and experimental therapeutics.

[33]  A. Lipkowski,et al.  Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. , 1989, The Journal of pharmacology and experimental therapeutics.

[34]  M. Adler,et al.  Effect of ambient temperature on the ability of mu-, kappa- and delta-selective opioid agonists to modulate thermoregulatory mechanisms in the rat. , 1994, The Journal of pharmacology and experimental therapeutics.

[35]  P. Seeburg,et al.  Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact. , 1989, The EMBO journal.

[36]  S. Kaneko,et al.  Cloning and expression of a cDNA for the rat kappa-opioid receptor. , 1993, FEBS letters.

[37]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[38]  J. K. Chang,et al.  Potent morphiceptin analogs: structure activity relationships and morphine-like activities. , 1983, The Journal of pharmacology and experimental therapeutics.

[39]  G. Uhl,et al.  Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras. , 1994, The Journal of biological chemistry.

[40]  H. Akil,et al.  Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Lewis,et al.  Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. , 1988, The Journal of pharmacology and experimental therapeutics.

[42]  P. Schiller,et al.  Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Lipkowski,et al.  Bimorphinans as highly selective, potent kappa opioid receptor antagonists. , 1987, Journal of medicinal chemistry.

[44]  Y. Itzhak Multiple Opioid Binding Sites , 1988 .

[45]  V. Hruby,et al.  Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. , 1984, The Journal of pharmacology and experimental therapeutics.

[46]  R. Lahti,et al.  Properties of a selective kappa agonist, U-50,488H. , 1982, Life sciences.

[47]  S. Rane,et al.  Nucleotide-independent modulation of Ca(2+)-dependent K+ channel current by a mu-type opioid receptor. , 1994, Molecular pharmacology.

[48]  T. Nakagawa,et al.  DAMGO, a mu-opioid receptor selective agonist, distinguishes between mu- and delta-opioid receptors around their first extracellular loops. , 1995, FEBS letters.

[49]  K. Mori,et al.  Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. , 1993, FEBS letters.

[50]  H. Kosterlitz,et al.  CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN , 1981 .

[51]  I. Zagon,et al.  Zeta (ξ), a growth-related opioid receptor in developing rat cerebellum: identification and characterization , 1991, Brain Research.

[52]  S. Salvadori,et al.  Frog skin opioid peptides: a case for environmental mimicry. , 1994, Environmental health perspectives.

[53]  R. Zukin,et al.  Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Brownstein A brief history of opiates, opioid peptides, and opioid receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H. Loh,et al.  Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. , 1992, Molecular pharmacology.

[56]  G. Pasternak,et al.  Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor , 1995, FEBS letters.

[57]  T. Petcher,et al.  Bremazocine: a potent, long-acting opiate kappa-agonist. , 1980, Life sciences.

[58]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.

[59]  M. Dichter,et al.  The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells , 1994, Neuroscience.

[60]  T. Cicero,et al.  Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor. , 1990, The Journal of pharmacology and experimental therapeutics.

[61]  A. Gintzler,et al.  Bimodal Opioid Regulation of Cyclic AMP Formation: Implications for Positive and Negative Coupling of Opiate Receptors to Adenylyl Cyclase , 1994, Journal of neurochemistry.

[62]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[63]  G. Bell,et al.  Molecular biology of opioid receptors , 1993, Trends in Neurosciences.

[64]  H. Yamamura,et al.  Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium. , 1993, European journal of pharmacology.

[65]  D. L. Larson,et al.  A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.

[66]  P. Portoghese,et al.  Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone. , 1992, Life sciences.

[67]  M. Yeadon,et al.  Multiple opioid receptors mediate the respiratory depressant effects of fentanyl-like drugs in the rat. , 1990, General pharmacology.

[68]  P. Schiller,et al.  TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. , 1993, Journal of medicinal chemistry.

[69]  A. Faden,et al.  Kappa opioid receptors modulate cardiorespiratory function in hindbrain nuclei of rat , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  F. Dudek,et al.  Direct effects of an opioid peptide selective for μ-receptors: Intracellular recordings in the paraventricular and supraoptic nuclei of the guinea-pig , 1990, Neuroscience.

[71]  G. Pasternak,et al.  Multiple mu opiate receptors. , 1986, Life sciences.

[72]  S. Childers,et al.  Opioid‐Inhibited Adenylyl Cyclase in Rat Brain Membranes: Lack of Correlation with High‐Affinity Opioid Receptor Binding Sites , 1992, Journal of neurochemistry.

[73]  L. Hood,et al.  Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Milligan,et al.  Immunoprecipitation of opioid receptor-Go-protein complexes using specific GTP-binding-protein antisera. , 1995, The Biochemical journal.

[75]  H. Akil,et al.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.

[76]  M. Adler,et al.  Effect of μ-, κ-, and δ-selective opioid agonists on thermoregulation in the rat , 1992, Pharmacology Biochemistry and Behavior.

[77]  B. Moore,et al.  Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain. , 1993, The Journal of pharmacology and experimental therapeutics.

[78]  A. Faden,et al.  Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus , 1984, Neuropharmacology.

[79]  P. Schiller,et al.  Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP. , 1993, Life sciences.

[80]  W. E. Wilson,et al.  Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors. , 1989, The Journal of biological chemistry.

[81]  J. Bidlack,et al.  The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein. , 1993, The Journal of pharmacology and experimental therapeutics.

[82]  L. Terenius Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. , 2009, Acta pharmacologica et toxicologica.

[83]  M. Millan Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli. , 1989, The Journal of pharmacology and experimental therapeutics.

[84]  S. Snyder,et al.  Characterization of an endogenous morphine-like factor(enkephalin) in mammalian brain. , 1976, Molecular pharmacology.

[85]  A. Goldstein,et al.  Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[86]  B. Roques,et al.  Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. , 1983, Biochemical and biophysical research communications.

[87]  H. Loh,et al.  Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. , 1995, Brain research. Molecular brain research.

[88]  Stanley N Cohen,et al.  Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor , 1979, Nature.

[89]  B. Gaehwiler,et al.  Opiate antagonistic properties of an octapeptide somatostatin analog. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[90]  D. Rees,et al.  CI‐977, a novel and selective agonist for the κ‐opioid receptor , 1990, British journal of pharmacology.

[91]  H. Rhim,et al.  Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[92]  V. Hruby,et al.  Conformationally restricted analogs of somatostatin with high mu-opiate receptor specificity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[93]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[94]  W. Jin,et al.  Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[95]  M Price,et al.  Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate. , 1989, Molecular pharmacology.

[96]  R. North,et al.  Opiate-receptor interactions on single locus coeruleus neurones. , 1984, Molecular pharmacology.

[97]  P. Portoghese,et al.  7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice. , 1995, Journal of medicinal chemistry.

[98]  T. Miyata,et al.  cDNA cloning and regional distribution of a novel member of the opioid receptor family , 1994, FEBS letters.

[99]  P. Portoghese,et al.  A highly selective δ1-opioid receptor antagonist : 7-benzylidenenaltrexone , 1992 .

[100]  P. Portoghese,et al.  Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. , 1991, The Journal of pharmacology and experimental therapeutics.

[101]  L. Terenius,et al.  ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEY , 1975, British journal of pharmacology.

[102]  A. Randich,et al.  The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine , 1993, Brain Research.

[103]  R. Taussig,et al.  Inhibition of the omega-conotoxin-sensitive calcium current by distinct G proteins. , 1992, Neuron.

[104]  J. Leander A kappa opioid effect: increased urination in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.

[105]  G. Uhl,et al.  Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover. , 1994, Neuroreport.

[106]  C. Chen,et al.  Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. , 1994, The Journal of biological chemistry.

[107]  T. Nakazawa,et al.  Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice. , 1991, The Journal of pharmacology and experimental therapeutics.

[108]  W. Bowen,et al.  Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. , 1993, The Journal of pharmacology and experimental therapeutics.

[109]  L. S. Bye,et al.  Characterization of the cloned human mu opioid receptor. , 1995, The Journal of pharmacology and experimental therapeutics.

[110]  P. Portoghese,et al.  A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. , 1993, The Journal of biological chemistry.

[111]  A. Goldstein,et al.  Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. , 1984, Molecular pharmacology.

[112]  G. Bell,et al.  Distribution of κ Opioid Receptor mRNA in Adult Mouse Brain: An in Situ Hybridization Histochemistry Study , 1994, Molecular and Cellular Neuroscience.

[113]  J. Reubi,et al.  Somatostatin Receptors , 1997, Trends in Endocrinology & Metabolism.

[114]  Á. Pazos,et al.  A comparative study in rats of the respiratory depression and analgesia induced by μ- and δ-opioid agonists , 1984 .

[115]  M. Olianas,et al.  Naturally occurring opioid receptor agonists stimulate adenylate cyclase activity in rat olfactory bulb. , 1991, Molecular pharmacology.

[116]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[117]  Á. Márki,et al.  CHARACTERIZATION OF KAPPA OPIOID RECEPTORS WITH TRITIATED norBNI , 1995 .

[118]  C. N. Honda,et al.  Immunohistochemical localization of delta‐ and mu‐opioid receptors in primate spinal cord , 1995, Neuroreport.

[119]  D. Regoli,et al.  RAT VAS DEFERENS: A SPECIFIC BIOASSAY FOR ENDOGENOUS OPIOID PEPTIDES , 1978, British journal of pharmacology.

[120]  S. Harrison,et al.  GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity , 1992, British journal of pharmacology.

[121]  T. Katada,et al.  A subtype of opioid κ‐receptor is coupled to inhibition of Gil‐mediated phospholipase C activity in the guinea pig cerebellum , 1995, FEBS letters.

[122]  V. Hruby,et al.  Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors , 1986 .

[123]  F. Cardinaux,et al.  A SYNTHETIC ENKEPHALIN ANALOG WITH PROLONGED PARENTERAL AND ORAL ANALGESIC ACTIVITY , 1977 .

[124]  Stanley J. Watson,et al.  Cloning and pharmacological characterization of a rat μ opioid receptor , 1993, Neuron.

[125]  M. Wick,et al.  Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. , 1994, Brain research. Molecular brain research.

[126]  M. Spedding,et al.  X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes. , 1996, Pharmacological reviews.

[127]  G. Uhl,et al.  Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. , 1994, FEBS letters.

[128]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[129]  A H BECKETT,et al.  SYNTHETIC ANALGESICS: STEREOCHEMICAL CONSIDERATIONS , 1954, The Journal of pharmacy and pharmacology.

[130]  Y. Wong,et al.  Regulation of Multiple Effectors by the Cloned δ‐Opioid Receptor: Stimulation of Phospholipase C and Type II Adenylyl Cyclase , 1995, Journal of neurochemistry.

[131]  G. Haddad,et al.  Opposite effects of the δ- and μ-opioid receptor agonists on ventilation in conscious adult dogs , 1984, Brain Research.

[132]  W. Sadee,et al.  Characterization of a Labile Naloxone Binding Site (λ Site) in Rat Brain , 1985 .

[133]  P. Portoghese,et al.  TENA, a selective kappa opioid receptor antagonist. , 1985, Life sciences.

[134]  M. Marcoli,et al.  The opioid receptors in the hamster vas deferens are of the δ-type , 1985, Neuropharmacology.

[135]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[136]  Stanley J. Watson,et al.  Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.

[137]  C. Li,et al.  Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[138]  V. Hruby,et al.  Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors. , 1988, Journal of medicinal chemistry.

[139]  W. Kromer The current status of opioid research on gastrointestinal motility. , 1989, Life sciences.

[140]  G. Pasternak,et al.  Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. , 1989, European journal of pharmacology.

[141]  S. Nakanishi,et al.  Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin , 1982, Nature.

[142]  C. Schmauss Spinal κ-opioid receptor-mediated antinociception is stimulus-specific , 1987 .

[143]  B. O'dowd,et al.  Cloning, Characterization, and Distribution of a μ‐Opioid Receptor in Rat Brain , 1994 .

[144]  R. Espinosa,et al.  Localization of the kappa opioid receptor gene to human chromosome band 8q11.2. , 1994, Genomics.

[145]  J. Champagnat,et al.  Different effects of and d opiate agonists on respiration , 1984 .

[146]  Shengwen Zhang,et al.  Identification of Dynorphins as Endogenous Ligands for an Opioid Receptor-like Orphan Receptor (*) , 1995, The Journal of Biological Chemistry.

[147]  V. Hruby,et al.  Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors. , 1988, The Journal of pharmacology and experimental therapeutics.

[148]  T. Burks,et al.  Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test. , 1987, The Journal of pharmacology and experimental therapeutics.

[149]  P. Portoghese,et al.  A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists. , 1993, Journal of medicinal chemistry.

[150]  J. Mathiasen,et al.  [D-Pen2,L-Pen5]enkephalin induced analgesia in the jimpy mouse: in vivo evidence for delta-receptor mediated analgesia. , 1987, European journal of pharmacology.

[151]  T. Reisine,et al.  Agonists and antagonists bind to different domains of the cloned kappa opioid receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[152]  R. Spanagel,et al.  Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. , 1994, European journal of pharmacology.

[153]  R. Macdonald,et al.  Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[154]  B. Ozenberger,et al.  cDNA Cloning of an orphan opiate receptor gene family member and its splice variant , 1994, FEBS letters.

[155]  D. Manallack,et al.  Psychotomimetic σ-opiates and PCP , 1986 .

[156]  J. Kleinman,et al.  Interaction of opioid peptides and other drugs with multiple kappa receptors in rat and human brain. Evidence for species differences , 1992, Peptides.

[157]  J. Fishman,et al.  Etonitazene: an opioid selective for the mu receptor types. , 1993, Life sciences.

[158]  B. Morgan,et al.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. , 1981, European journal of pharmacology.

[159]  G Vassart,et al.  ORL1, a novel member of the opioid receptor family , 1994, FEBS letters.

[160]  M. E. Meyer,et al.  Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities , 1993, Pharmacology Biochemistry and Behavior.

[161]  M. Olianas,et al.  Activation of Opioid and Muscarinic Receptors Stimulates Basal Adenylyl Cyclase but Inhibits Ca2+/Calmodulin‐ and Forskolin‐Stimulated Enzyme Activities in Rat Olfactory Bulb , 1994, Journal of neurochemistry.

[162]  D. Hammond,et al.  Antinociception after intracerebroventricular administration of naltrindole in the mouse. , 1992, European journal of pharmacology.

[163]  T. Cicero,et al.  Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for κ opioid receptor subtypes , 1988 .

[164]  G. Bell,et al.  Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[165]  H. Kosterlitz,et al.  COMPARISON OF THE BINDING CHARACTERISTICS OF TRITIATED OPIATES AND OPIOID PEPTIDES , 1980, British journal of pharmacology.

[166]  T. Yaksh,et al.  In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.

[167]  D. Scopes,et al.  A series of novel, highly potent and selective agonists for the κ‐opioid receptor , 1990 .

[168]  B. Giros,et al.  Chromosomal localization of opioid peptide and receptor genes in the mouse. , 1995, Life sciences.

[169]  C. Fowler,et al.  μ-, δ-, κ-Opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments , 1994, Neurochemistry International.

[170]  H. Loh,et al.  Genomic structure and analysis of promoter sequence of a mouse la opioid receptor gene , 2022 .

[171]  D. Barra,et al.  Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors. , 1989, European journal of pharmacology.

[172]  P. Portoghese A new concept on the mode of interaction of narcotic analgesics with receptors. , 1965, Journal of medicinal chemistry.

[173]  H. Loh,et al.  Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins. , 1994, Molecular pharmacology.

[174]  R. Raffa,et al.  Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. , 1988, The Journal of pharmacology and experimental therapeutics.

[175]  V. Hruby,et al.  Quantitative autoradiography of [3H]CTOP binding to mu opioid receptors in rat brain. , 1988, Life sciences.

[176]  M. Chesselet,et al.  Expression of Mu opioid receptor mRNA in rat brain: An in situ hybridization study at the single cell level , 1994, The Journal of comparative neurology.

[177]  C. Chavkin,et al.  Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation , 1991, Neuron.

[178]  B. Roques,et al.  [3H]Ohmefentanyl preferentially binds to μ-opioid receptors but also labels σ-sites in rat brain sections , 1991 .

[179]  K. Mori,et al.  cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for κ‐subtype‐selective ligands , 1993, FEBS letters.

[180]  K. Shen,et al.  Cholera toxin-A subunit blocks opioid excitatory effects of sensory neuron action potentials indicating mediation by Gs-linked opioid receptors , 1990, Brain Research.

[181]  A Goldstein,et al.  Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[182]  B. Roques,et al.  Comparative binding properties of linear and cyclic δ‐selective enkephalin analogues: [3H]‐[D‐Thr2, Leu5] enkephalyl‐Thr6 and [3H]‐[D‐Pen2, D‐Pen5] enkephalin , 1985, FEBS letters.

[183]  V. Erspamer,et al.  Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[184]  M Satoh,et al.  Molecular pharmacology of the opioid receptors. , 1995, Pharmacology & therapeutics.

[185]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[186]  C. Stein,et al.  Peripheral Mechanisms of Opioid Analgesia , 1993, Anesthesia and analgesia.